<div id="readability-page-1">11:47 AM EST, 01/02/2026 (MT Newswires) -- Burcon NutraScience ( BRCNF ) , up more than 10% on last look, said Friday that it has closed the first tranche of its non-brokered private placement of convertible debentures, raising $1.25 million through a direct investment from its manufacturing partner owners.The company will close the private placement in two tranches, for an aggregate principal amount of up to $6.3 million. It expects to close the second and final tranche of the private placement following the special meeting of shareholders on Feb. 20, a statement said.Company insiders and Burcon's manufacturing partner owners are investing a minimum of $5 million in principal amounts. The private placement has been conditionally approved by the Toronto Stock Exchange subject to Burcon complying with the terms of such conditional approval, including receipt of disinterested shareholder approval.Burcon shares are up $0.17, to $1.80, on the Toronto Stock Exchange.Price: 1.80, Change: +0.17, Percent Change: +10.43 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

BRCND

Burcon NutraScience (BRCNF) 的股票在公司完成首批可转换债券私募配售后上涨超过 10%，筹集了 125 万美元。此次配售的总目标为 630 万美元，第二批预计将在 2 月 20 日的股东会议后进行。多伦多证券交易所已有条件批准此次配售，待符合相关条款。Burcon 的股票上涨了 0.17 美元，至 1.80 美元，反映出 10.43% 的变化

Burcon NutraScience 股价上涨 10%，因为完成了债券融资的首笔交易